AquaVerify
Whitepaper for laboratories, utilities and distributors preparing risk-based water quality workflows under the recast EU Drinking Water Directive.
Directive (EU) 2020/2184 reinforces a risk-based approach to drinking water quality and extends the microbiological conversation to include somatic coliphages in treatment performance and raw water monitoring contexts. For laboratories and suppliers, the opportunity is to translate regulatory language into sample plans, method readiness and clear evidence records.
A strong implementation brief should connect the regulatory driver with the real operational workflow: sampling locations, sample volumes, method route, controls, acceptance criteria, reporting language and escalation process.
AquaVerify connects coliphage-focused products, laboratory essentials and AquaVerify Cloud so a buyer can move from whitepaper research to product selection, SaaS workflow design or distributor/OEM conversation without losing context.
No. It is practical marketing and technical orientation. Laboratories, water suppliers and distributors should confirm requirements with their competent authority, accreditation body and quality system.
They strengthen the viral indicator discussion around treatment performance and microbiological risk, especially when a programme needs evidence beyond traditional bacterial indicators.